"10.1371_journal.pone.0043310","none","2012-08-17T00:00:00Z","Mario A Cabrera-Salazar; Matthew DeRiso; Scott D Bercury; Lingyun Li; John T Lydon; William Weber; Nilesh Pande; Mandy A Cromwell; Diane Copeland; John Leonard; Seng H Cheng; Ronald K Scheule","Genzyme Corporation, Framingham, Massachusetts, United States of America","Conceived and designed the experiments: MC-S MD SDB LL JTL WW NP MAC DC JL SHC RKS. Performed the experiments: MC-S MD SDB LL JTL WW NP MAC. Analyzed the data: MC-S MD SDB LL JTL WW NP MAC DC JL SHC RKS. Contributed reagents/materials/analysis tools: LL DC JL WW NP DC JL. Wrote the paper: MC-S RKS.","Mario A. Cabrera-Salazar, Matthew DeRiso, Scott D. Bercury, Lingyun Li, Nilesh Pande, William Weber, Diane Copeland, John Leonard, Seng H. Cheng and Ronald K. Scheule are all employees of Genzyme Corporation (a subsidiary of Sanofi-aventis Group), covering therapeutic applications for GZ-161 and has received an unrestricted study grant from Genzyme Corporation to investigate modulation of sphingolipid metabolism. The described studies were part of the drug development program at Genzyme Corporation. There are no further patents, products in development or marketed products to declare. This does not alter the authorsâ€™ adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","08","Mario A Cabrera-Salazar","MACS",12,TRUE,12,8,12,2,TRUE,TRUE,FALSE,0,NA,FALSE
